Dr Than Tun Oo, MBBS, DO | |
Turner Street, Fagatogo, Lbj Tropical Medical Center, Pago Pago American Samoa, AS 96799-1684 | |
(684) 633-1222 | |
(684) 633-5913 |
Full Name | Dr Than Tun Oo |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | Turner Street, Fagatogo, Pago Pago American Samoa, American Samoa |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1669481610 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 3063-C (American Samoa) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Than Tun Oo, MBBS, DO Turner Street, Fagatogo, Lbj Tropical Medical Center, Pago Pago American Samoa, AS 96799-1684 Ph: (684) 633-1222 | Dr Than Tun Oo, MBBS, DO Turner Street, Fagatogo, Lbj Tropical Medical Center, Pago Pago American Samoa, AS 96799-1684 Ph: (684) 633-1222 |
News Archive
At the 2018 Annual Meeting of the International Association of Food Protection (www.foodprotection.org/), Bruker announces a standardized workflow for any microbial isolate confirmation and identification in food microbiology.
A recent report published in the New England Journal of Medicine has revealed that the COVID-19 vaccine developed by Moderna, Inc, USA, is capable of inducing robust and durable antibody responses for at least six months post-vaccination.
The American Society of Human Genetics has named Kay E. Davies, DPhil, Dr. Lee's professor of anatomy, associate head of the medical sciences division; and director of the Medical Research Council Functional Genomics Unit in the department of physiology, anatomy and genetics at the University of Oxford, the 2015 recipient of the annual William Allan Award.
MedGenesis Therapeutix Inc. ("MedGenesis"), a biopharmaceutical company developing and commercializing innovative treatments for patients with serious central nervous system (CNS) diseases, announced today that it has successfully entered into an agreement with Amgen Inc. ("Amgen"), granting MedGenesis an exclusive, worldwide license for glial cell line-derived neurotrophic factor (GDNF) protein in CNS and non-CNS indications, subject to the rights of a co-exclusive licensee for CNS indications in certain countries, as further described below.
A specific goal to eat a set number of daily servings of low-glycemic-index foods can improve dietary habits of people with Type 2 diabetes, according to new research.
› Verified 5 days ago